Fast Tracking For Fun and Profit

Last week, on The Big Wakeup Call, Ryan and I discussed a new Alzheimer’s drug that was zooming towards public use. And I mean ZOOOOOOOMING! From a preliminary, and vague, research paper released in November of 2019, to opening trials on humans in February of 2020 kind of zooming. That kind of time line is essentially unheard of in the world of medicines. I’ve written, on several occasions, about the trials and tribulations facing new treatments for Alzheimer’s. The FDA’s own rules would seem to preclude any such speed, but…

Read More